OR WAIT 15 SECS
EMD Millipore expands its Provantage upstream bioproduction services into North America.
EMD Millipore, the life science division of Merck KGaA, reported the expansion of its upstream services into North America as part of its Provantage biodevelopment and clinical supply offering. The company's Massachusetts facilities will now offer upstream capabilities including media and feed screening, small-scale material production, and optimization of conditions for scale-up and technology transfer.
This expansion allows EMD Millipore's North American customers to access the same services European customers have received at the company's GMP biodevelopment center in Martillac, France.
Source: EMD Millipore